Trial · NCT04467983
Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone
NCT04467983, Phase 4, Active not recruiting, Hospital for Special Surgery, New York
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone. Trials, record NCT04467983. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04467983
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone
- NCT number
- NCT04467983
- Status
- Active not recruiting
- Phases
- Phase 4
- Enrollment
- 70 participants, estimated
- Lead sponsor
- Hospital for Special Surgery, New York
- Conditions
- Osteoporosis, Postmenopausal
- Interventions
- Denosumab Injection, Abaloparatide
- First posted
- 2020-07-13
- Last updated
- 2026-10-13
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Bone mineral density changes at total hip and lumbar spine | 18 months | Group differences in BMD increment at total hip and lumbar spine at 18 months. |
| Secondary | Bone mineral density changes in increments | 6, 12, 18 months | Group Differences in BMD increments: of lumbar spine and total hip at 6 and 12 months. of femoral neck, and 1/3 radius at 6, 12 and 18 months. Group Differences in BMD increments: of lumbar spine and total hip at 6 and 12 months. of femoral neck, and 1/3 radius at 6, 12 and 18 months. Group Differences in BMD increments: of lumbar spine and total hip at 6 and 12 months. of femoral neck, and 1/3 radius at 6, 12 and 18 months. Group differences in BMD increments of lumbar spine and total hip (at 6 and 12 months) and of femoral neck and 1/3 distal radius (at 6, 12, and 18 months) |
| Secondary | Trabecular Bone Score changes | 18 months | Group differences in Trabecular Bone Score at 18 months |
| Secondary | Within Group Increments in bone mineral density (vs baseline) | 6, 12, 18 months | Within Group Increments in bone mineral density vs baseline of lumbar spine (at 6, 12, and 18 months) and of total hip, femoral neck, and distal 1/3 radius (at 6, 12, and 18 months) |
| Secondary | Differences in biochemical bone turnover markers | 3, 6, 12, 18 months | Within and between group differences in biochemical bone turnover markers (P1NP and CTX) at 3, 6, 12, and 18 months |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers5
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04467983
GET https://conductscience.org/api/trials/v1/NCT04467983/registered